Apyx Medical (APYX) Accounts Payables (2010 - 2026)

Apyx Medical (APYX) has 17 years of Accounts Payables data on file, last reported at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 14.06% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 14.06% YoY), and the FY2025 full-year result was $3.1 million, up 16.94% from the prior year.
• Accounts Payables for Q1 2026 stood at $2.6 million, down from $3.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $3.2 million in Q3 2025 and bottomed at $1.9 million in Q1 2023.
• The 5-year median for Accounts Payables is $2.6 million (2022), against an average of $2.5 million.
• The widest annual swing landed in 2022, when Accounts Payables plunged 32.0%; it then soared 68.23% in 2025.
• A 5-year view of Accounts Payables shows it stood at $2.7 million in 2022, then grew by 1.61% to $2.7 million in 2023, then slipped by 3.58% to $2.6 million in 2024, then climbed by 16.94% to $3.1 million in 2025, then dropped by 14.03% to $2.6 million in 2026.
• The last three Accounts Payables figures came in at $2.6 million (Q1 2026), $3.1 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.

Peer Comparison